Regulation, Function, and Expression of Matrix Metalloproteinase-9 in Colon, Lung, and Breast Cancers In Silico and Experimental Methods From Iraqi Metastatic Patients
By:
References
- Buttacavoli, M., Di Cara, G., Roz, E., Pucci-Minafra, I., Feo, S., & Cancemi, P. (2021). Integrated multi-omics investigations of metalloproteinases in colon cancer: Focus on MMP2 and MMP9.
International journal of molecular sciences ,22 (22), 12389. - Jafarian, A. H., Reisi, H., & Roshan, N. M. (2020). Matrix metalloproteinase-9 (MMP-9) expression in non-small cell lung carcinoma and its association with clinicopathologic factors.
Iranian Journal of Pathology ,15 (4), 326. - Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S., & Barsouk, A. (2021). Epidemiology of lung cancer.
Contemporary Oncology/Współczesna Onkologia ,25 (1), 45–52. - Januškevičienė, I., & Petrikaitė, V. (2019). Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations.
Life sciences ,239 , 117009. - Venkitaraman, A. R. (2019). How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?.
DNA repair ,81 , 102668. - Zhang, B., Zhang, L., Yue, D., Li, C., Zhang, H., Ye, J., ... & Wang, C. (2020). Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis.
Translational Lung Cancer Research ,9 (4), 1187. - Costea, T., Vlad, O. C., Miclea, L. C., Ganea, C., Szöllősi, J., & Mocanu, M. M. (2020). Alleviation of multidrug resistance by flavonoid and nonflavonoid compounds in breast, lung, colorectal and prostate cancer.
International journal of molecular sciences ,21 (2), 401. - Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020). Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
European journal of medicinal chemistry ,194 , 112260. - Niland, S., Riscanevo, A. X., & Eble, J. A. (2021). Matrix metalloproteinases shape the tumor microenvironment in cancer progression.
International journal of molecular sciences ,23 (1), 146. - Huang, H. (2018). Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances.
Sensors ,18 (10), 3249. - Jiang, H., & Li, H. (2021). Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic review and meta-analysis.
BMC cancer ,21 , 1–13. - Zhang, H., Zhao, B., Zhai, Z. G., Zheng, J. D., Wang, Y. K., & Zhao, Y. Y. (2021). Expression and clinical significance of MMP-9 and P53 in lung cancer.
European Review for Medical & Pharmacological Sciences ,25 (3). - Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., ... & Martinez-Fierro, M. L. (2020). The roles of matrix metalloproteinases and their inhibitors in human diseases.
International journal of molecular sciences ,21 (24), 9739. - Joseph, C., Alsaleem, M., Orah, N., Narasimha, P. L., Miligy, I. M., Kurozumi, S., ... & Rakha, E. A. (2020). Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Breast cancer research and treatment ,182 , 267–282. - Chien, Y. C., Liu, L. C., Ye, H. Y., Wu, J. Y., & Yu, Y. L. (2018). EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.
American journal of cancer research ,8 (3), 422. - Hamad, H. A., Enezei, H. H., Alrawas, A., Zakuan, N. M., Abdullah, N. A., Cheah, Y. K., & Hashim, N. F. M. (2020). Identification of potential chemical substrates as fuel for hypoxic tumors that may be linked to invadopodium formation in hypoxia-induced MDA-MB-231 breast-cancer cell line.
Molecules ,25 (17), 3876. - Hamad, H. A., Gopalsamy, B., Kqueen, C. Y., & Hashim, N. F. M. (2019). Potential Ability of Phytochemical in Inhibition of Invadopodia Formation and HIF-1α in Cancer Metastasis.
Malaysian Journal of Medicine & Health Sciences ,15 . - Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., ... & von Mering, C. (2021). The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets.
Nucleic acids research ,49 (D1), D605–D612. - Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Nucleic acids research ,45 (W1), W98–W102. - Digre, A., & Lindskog, C. (2021). The Human Protein Atlas—Spatial localization of the human proteome in health and disease.
Protein Science ,30 (1), 218–233. - Labeda, I., Uwuratuw, J. A., Hendarto, J., Lusikooy, R. E., Sampetoding, S., Kusuma, M. I., ... & Faruk, M. (2023). Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study.
Annals of Medicine and Surgery ,85 (9), 4277–4282. - Chien, Y. C., Liu, L. C., Ye, H. Y., Wu, J. Y., & Yu, Y. L. (2018). EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.
American journal of cancer research ,8 (3), 422. - Joseph, C., Alsaleem, M., Orah, N., Narasimha, P. L., Miligy, I. M., Kurozumi, S., ... & Rakha, E. A. (2020). Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Breast cancer research and treatment ,182 , 267–282. - Tan, H., Zhang, M., Xu, L., Zhang, X., & Zhao, Y. (2022). Gypensapogenin H suppresses tumor growth and cell migration in triple-negative breast cancer by regulating PI3K/AKT/NF-κB/MMP-9 signaling pathway.
Bioorganic Chemistry ,126 , 105913. - Li, C., Ma, Y., Fei, F., Zheng, M., Li, Z., Zhao, Q., ... & Zhang, S. (2020). Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Journal of Cancer ,11 (4), 826. - Kang, C., Wang, L., Wang, D., Zhang, X., & Chen, J. (2020). Lung cancer A549 cells suppressed with overexpressed HNF1B or PCDHA13 inhibited PI3K/AKT phosphorylation.
Translational Cancer Research ,9 (6), 3819. - Peeney, D., Fan, Y., Nguyen, T., Meerzaman, D., & Stetler-Stevenson, W. G. (2019). Matrisome-associated gene expression patterns correlating with TIMP2 in cancer.
Scientific reports ,9 (1), 20142. - Lu, L., Liu, Q., Wang, P., Wu, Y., Liu, X., Weng, C., ... & Liu, G. (2019). MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
BMC cancer ,19 , 1–11. - Mao, Y., Su, C., Yang, H., Ma, X., Zhao, F., Qu, B., ... & Cui, Y. (2024). PI3K/AKT/mTORC1 signalling pathway regulates MMP9 gene activation via transcription factor NF-κB in mammary epithelial cells of dairy cows.
Animal Biotechnology , 2314100. - Wu, L., Wang, J., Zhao, J., Yao, R., Xu, Q., Ma, L., & Liu, J. (2022). Bioinformatics analysis identified RGS4 as a potential tumor promoter in glioma.
Pathology-Research and Practice ,240 , 154225. - Gu, Y., Yu, J., Ding, C., Zhou, Y., Yang, J., Yu, W., ... & Huang, H. (2021). Flavonoid GL-V9 suppresses invasion and migration of human colorectal cancer cells by inhibiting PI3K/Akt and MMP-2/9 signaling.
Journal of Cancer ,12 (15), 4542. - Jian, F., Yanhong, J., Limeng, W., Guoping, N., Yiqing, T., Hao, L., & Zhaoji, P. (2022). TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
International immunopharmacology ,110 , 109008. - Costanzo, L., Soto, B., Meier, R., & Geraghty, P. (2022). The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs.
Pulmonary Medicine ,2022 . - Chen, W. Q., Yang, S. J., Xu, W. X., Deng, F., Wang, D. D., & Tang, J. H. (2021). Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
Medicine ,100 (42), e27489. - Yu, J., He, Z., He, X., Luo, Z., Lian, L., Wu, B., ... & Chen, H. (2021). Comprehensive analysis of the expression and prognosis for MMPs in human colorectal cancer.
Frontiers in Oncology ,11 , 771099. - Augoff, K., Hryniewicz-Jankowska, A., Tabola, R., & Stach, K. (2022). MMP9: a tough target for targeted therapy for cancer.
Cancers ,14 (7), 1847. - Rashid, Z. A., & Bardaweel, S. K. (2023). Novel matrix metalloproteinase-9 (MMP-9) inhibitors in cancer treatment.
International journal of molecular sciences ,24 (15), 12133.
Language: English
Page range: 19 - 28
Submitted on: Jun 17, 2024
Accepted on: Nov 18, 2024
Published on: Jun 10, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2025 Hamad Ali Hamad, Yamama Farouk Shakir, Omar Tareq Zaidan, Aymen Adnan Rafea, Nur Fariesha Md Hashim, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.